Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Spyre Therapeutics (SYRE) Q1 2021 Earnings
SYRE
10
May
Expected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-10
-6.74
-3.49
-0.23
Details
Expected EPS
-0.2286
Actual EPS
-7
Surprise EPS
-6.77
Surprise Percent
+2,962.12%
Description
Spyre Therapeutics (SYRE) has reported earnings of -7 per share for Q1 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login